CTSO - Cytosorbents Corp
0.883
-0.007 -0.793%
Share volume: 58,560
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.89
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-07-2024 | |
| Total revenue | 9.786 M | 9.895 M | 9.390 M | |
| Cost of revenue | 3.216 M | 3.392 M | 4.109 M | |
| Gross profit | 6.571 M | 6.503 M | 5.282 M | |
| -1.03% | -18.78% | |||
| Operating expenses | 11.496 M | 9.922 M | 9.678 M | |
| Selling general and admin | 9.248 M | 8.402 M | 7.827 M | |
| Research and development | 2.248 M | 1.520 M | 1.851 M | |
| Total expenses | 11.496 M | 9.922 M | 9.678 M | |
| -13.70% | -2.46% | |||
| Operating income | -4.926 M | -3.419 M | -4.396 M | |
| Ebit | -6.351 M | -3.963 M | -1.746 M | |
| Pretax income | -6.358 M | -4.143 M | -2.334 M | |
| -34.83% | -43.66% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -6.358 M | -4.143 M | -2.334 M | |
| 34.83% | 43.66% |
